pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 16·1 min read
save

OpenLoop Health says it can launch a virtual GLP-1 prescribing service in 24 hours

Jun 16, 2026·read at Endpoints ↗Neutral

OpenLoop Health says it can set up a telehealth operation that can prescribe GLP-1 medicines within a day.

The company provides the medical‑group infrastructure that powers multiple virtual care providers, handling licensing, prescribing and compliance.

According to the article, the process can be completed in as little as 24 hours, allowing entrepreneurs to launch a virtual care business quickly.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “How to launch a telehealth business in one day”

read at Endpoints ↗
82 words · retrieved Jun 16
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
GLP-1 receptor

related stories

  • May 19STAT+: Dexcom CEO hints at future uses for CGMSTAT
  • May 18Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugBioPharma Dive
  • May 18STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much moreSTAT
  • May 15FDA hold puts Aardvark Prader-Willi drug in limboBioPharma Dive
  • May 15India’s pharma industry is going global. But can it catch up to China?BioPharma Dive